Paper Details

  1. Home
  2. Paper Details

Naltrexone HCI/bupropion HCI for chronic weight management in obese adults: patient selection and perspectives.

Author: TekCenk

ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

The combination of naltrexone and bupropion, when used with lifestyle intervention and calorie reduction, is effective in inducing weight loss in obese individuals.
Paper Details　
Original Abstract of the Article :
Naltrexone, an opiate antagonist, and bupropion, a noradrenergic/dopaminergic antidepressant, have many effects on the reward systems of the brain. These medications impact eating behavior, presumably via their impact on food reward. However, only bupropion induces weight loss in obese individuals, ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4862388/

データ提供：米国国立医学図書館（NLM）

Naltrexone HCI/bupropion HCI for Chronic Weight Management in Obese Adults: Patient Selection and Perspectives

The struggle against obesity is a common challenge in our modern world. This study examines the efficacy of naltrexone/bupropion, a medication combination, for chronic weight management in obese adults. The authors focus on the role of patient selection and clinical strategies in maximizing the benefits of this treatment. They provide a comprehensive review of existing clinical trials and discuss the rationale for careful patient selection to minimize adverse effects and optimize positive outcomes.

A New Hope for Weight Management

The results indicate that the naltrexone/bupropion combination, when combined with lifestyle interventions and calorie reduction, can be a valuable tool for achieving clinically significant weight loss. However, the authors emphasize the need for careful patient selection to ensure optimal outcomes and mitigate potential side effects.

Navigating the Desert of Obesity: A Camel's Perspective

The fight against obesity is a long and arduous journey. This study sheds light on a potential oasis in the desert, offering a new way to address the challenges of weight management. Like a camel carefully navigating a treacherous landscape, the use of naltrexone/bupropion requires careful planning and an understanding of its potential benefits and risks. It's a reminder that the path to a healthier life requires a balanced approach, combining medication with lifestyle modifications for long-term success.

Dr.Camel's Conclusion

This research offers valuable insights into the potential of naltrexone/bupropion for weight management. It highlights the importance of careful patient selection and the integration of lifestyle interventions to achieve optimal outcomes. This study is a step towards finding more effective and personalized solutions for individuals struggling with obesity.

Date :
  1. Date Completed 2016-05-24
  2. Date Revised 2022-04-10
Further Info :

Pubmed ID

27217728

DOI: Digital Object Identifier

PMC4862388

Related Literature

Article Analysis
・Side Effects of naltrexone and bupropion
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.